USPTO serial 97531272
KINETIX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SETTLES LEWIS, SHAILA E
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KINETIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Kannapolis, NC
Kannapolis, NC
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for use in anesthesia, anxiolytics, and in the treatment and control of pain, hypertension, infection, hypotension, nausea, and anxiety; Medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for use in anesthesia, anxiolytics, and in the treatment and control of pain, hypertension, infection, hypotension, nausea, and anxiety; Pre-filled syringes containing pharmaceutical preparations for use in anesthesia, anxiolytics, and in the treatment and control of pain, hypertension, infection, hypotension, nausea, and anxiety; Injectable pharmaceuticals for use in anesthesia, anxiolytics, and in the treatment and control of pain, hypertension, infection, hypotension, nausea, and anxiety; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pre-filled syringes containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith; Kits comprised primarily of pharmaceutical preparations and substances for use in anesthesia, anxiolytics, and in the treatment and control of pain, hypertension, infection, hypotension, nausea, and anxiety, and also including syringes; Kits comprised primarily of pharmaceutical preparations and substances for use in anesthesia, anxiolytics, and in the treatment and control of pain, hypertension, infection, hypotension, nausea, and anxiety, and also including parts of syringes, namely, needles, barrels, and plungers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 25, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 25, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 29, 2024 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Feb 29, 2024 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Aug 22, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 27, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 27, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 7, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 19, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 24, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 5, 2022 | NWAP | NEW APPLICATION ENTERED | — |